When time means life or death for patients with serious diagnoses, eHealth Technologies™ drives powerful digital solutions that…
Category: Insights
Glycobiology Market: 14.23% Y-O-Y Growth Rate in 2022 | By Application (drug discovery and development, disease diagnostics, and others) and Geography – Global Forecast to 2026
The Glycobiology Market Share is expected to increase by USD 1.13 billionfrom 2021 to 2026, at an accelerated CAGR of 14.84%,…
Cano Health Announces Financial Results for the Fourth Quarter and Full Year 2021
Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and…
Neuromuscular Disease Therapeutics Market to Grow by USD 4.46 bn | Technavio
The neuromuscular disease therapeutics market is expected to grow by USD 4.46 bn from 2020 to 2025. The growth momentum…
Bronchitis Treatment Market Size to Grow by USD 1.12 bn | Technavio
The bronchitis treatment market size is expected to grow by USD 1.12 bnfrom 2021 to 2026. The growth momentum…
Blood-Grouping Reagents Market to Grow by USD 485.33 million | Increasing Prevalence of Chronic Disorders to Drive Growth | Technavio
The “Blood-Grouping Reagents Market by End-user (hospitals and blood banks, clinical laboratories, and academic and research…
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
Randomized phase 2 metastatic breast cancer trial (BRACELET-1) on track for top-line data in Q4 2022…
Ophthalmologists Welcome Genentech’s Vabysmo, Though Overthrowing Regeneron’s Eylea Will Be No Small Feat, Spherix Reports
Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular…
Patient Lateral Transfer Devices Market to Reach US$ 557.5 Million by 2028, Says Coherent Market Insights
According to Coherent Market Insights, the patient lateral transfer devices market expected to be valued at US$ 291.6 Million in 2021 and is…
Viveon Health Acquisition Corp. Announces Clarified Contribution Terms in Connection with the Extension Related to Merger Agreement with Suneva Medical
Viveon Health Acquisition Corp. (NYSE American: VHAQ) (“Viveon Health” or “VHAQ”), a special purpose acquisition company,…